Investors on the quest for market-beating returns often employ the strategy of stock picking. Making informed choices in stocks can greatly amplify your wealth.
The price of Capricor Therapeutics Inc (NASDAQ: CAPR) closed at $28.31 in the last session, down -1.91% from day before closing price of $28.86. In other words, the price has decreased by -$1.91 from its previous closing price. On the day, 1.33 million shares were traded. CAPR stock price reached its highest trading level at $29.36 during the session, while it also had its lowest trading level at $27.51.
Ratios:
We take a closer look at CAPR’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 3.59 and its Current Ratio is at 3.59. In the meantime, Its Debt-to-Equity ratio is 0.21 whereas as Long-Term Debt/Eq ratio is at 0.17.
Upgrades & Downgrades
In the most recent recommendation for this company, Alliance Global Partners on June 30, 2025, initiated with a Buy rating and assigned the stock a target price of $20.
On June 26, 2025, B. Riley Securities started tracking the stock assigning a Buy rating and target price of $21.
On May 20, 2025, Roth Capital started tracking the stock assigning a Buy rating and target price of $31.Roth Capital initiated its Buy rating on May 20, 2025, with a $31 target price.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, CAPR now has a Market Capitalization of 1540043648 and an Enterprise Value of 1210266880. For the stock, the TTM Price-to-Sale (P/S) ratio is 138.37 while its Price-to-Book (P/B) ratio in mrq is 15.43. Its current Enterprise Value per Revenue stands at 108.734 whereas that against EBITDA is -14.252.
Stock Price History:
The Beta on a monthly basis for CAPR is 0.22, which has changed by 0.8873333 over the last 52 weeks, in comparison to a change of 0.14778805 over the same period for the S&P500. Over the past 52 weeks, CAPR has reached a high of $40.37, while it has fallen to a 52-week low of $4.30. The 50-Day Moving Average of the stock is 86.70%, while the 200-Day Moving Average is calculated to be 169.31%.
Shares Statistics:
According to the various share statistics, CAPR traded on average about 2.72M shares per day over the past 3-months and 1077740 shares per day over the past 10 days. A total of 54.40M shares are outstanding, with a floating share count of 47.82M. Insiders hold about 12.11% of the company’s shares, while institutions hold 31.95% stake in the company. Shares short for CAPR as of 1765756800 were 5029282 with a Short Ratio of 1.85, compared to 1763078400 on 14153661. Therefore, it implies a Short% of Shares Outstanding of 5029282 and a Short% of Float of 10.290000000000001.
Earnings Estimates
The dynamic stock of Capricor Therapeutics Inc (CAPR) is currently attracting attention from 7.0 analysts actively involved in rating its market status.The consensus estimate for the next quarter is -$0.5, with high estimates of -$0.44 and low estimates of -$0.54.
Analysts are recommending an EPS of between -$2.02 and -$2.23 for the fiscal current year, implying an average EPS of -$2.16. EPS for the following year is $0.15, with 7.0 analysts recommending between $3.09 and -$2.36.
